| Description | Galcanezumab is a humanized IgG4 monoclonal antibody targeting the CGRP ligand, which binds to the ligand calcitonin gene-related peptide. Galcanezumab can be used to prevent and treat migraines or cluster headaches. |
| Synonyms | LY 2951742 |
| molecular weight | N/A |
| CAS | 1578199-75-3 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Yvette N Lamb. Galcanezumab: First Global Approval. Drugs. 2018 Nov;78(16):1769-1775. |